Yael P. Mosse is a tenured Associate Professor at The Children’s Hospital of Philadelphia and the Perelman School of Medicine of the University of Pennsylvania. Her clinical and research specialty is neuroblastoma, a cancer that starts in the nerve tissues of infants and young children. She received her M.D. from the Sackler School of Medicine, Tel Aviv, Israel, in 1997, joining the Children’s Hospital residency program that year, followed by fellowship training at the same hospital starting in 2000. Dr. Mosse trained in the laboratory of John Maris, MD and now has her own independent NIH-funded research program where we investigate the hereditary predisposition and progression of neuroblastoma with a focus on drug development. The broad goal of her research program is to improve cure rates for the childhood cancer neuroblastoma by discovering the genetic basis of the disease and translating rationale therapeutic opportunities that are more effective and less toxic to the clinic.